News + Filings Transactions
|
SV7 Impact Medicine Fund LP
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 998.5k | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 998.5k | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 302.6k | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 302.6k | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 9.5M | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 9.5M | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 2.9M | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 2.9M | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 998.5k | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 998.5k | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 302.6k | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Common Stock | 302.6k | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Purchase | Common Stock | 312.5k | $16.00 | $5M | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Purchase | Common Stock | 312.5k | $16.00 | $5M | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 9.5M | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series B Convertible Preferred Stock | 9.5M | $0.00 | $0 | See footnote | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 2.9M | $0.00 | $0 | | 10/26/2021 |
| 10/26/2021 | Xilio Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 2.9M | $0.00 | $0 | See footnote | 10/26/2021 |
|